ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 356777 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 356777; 2) Community: the network communities that were significantly associated with the response to NSC 356777; 3) Molecule: the relationships between components within communities and NSC 356777; 4) MDR: the compounds that were significantly associated with the NSC 356777.

NSC Compound Enrichment Correlation
NSC 745098 21-[2-(N,N-dimethylamino)ethyl]-oxy-.7.alpha.-methyl-19-norpregna-1,3,5(10),17(20)-tetraen-3-ol citrate salt 0.00671035899671664 0.042973998
NSC 755412 Null 0.00671035899671664 0.10692508
NSC 756355 GW794607X 0.00671035899671664 0.10280506
NSC 86368 Null 0.00671035899671664 0.17515278
NSC 681638 Camptothecin Derivative 0.00705866970012644 0.1766967
NSC 729831 2-{4-[(1E)-3-pyridine-4-yltriaz-1-enyl]phenyl}-1H-benzimidaz ole 0.00705866970012644 0.22065319
NSC 734201 Null 0.00705866970012644 -0.18535307
NSC 750148 3-(2-Hydroxy-5-chloro-4-methylphenyl)-5-(2-phenylethene)-1-(4-sulfamylphenyl)-pyrazoline 0.00705866970012644 -0.26184231
NSC 751623 Null 0.00705866970012644 0.22585045
NSC 287459 Cytarabine AY 0.00705866970012649 0.43040305
Total:62  Current:8    [First] [Prev] [Next] [Last]